daratumumab Articles
Genmab leaps on $1.1 billion daratumumab deal with Janssen
31 August 2012
More news briefs from ASH meeting
14 December 2011
Showing 1-4 of 4 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
